Skip to main content

Table 2 Multivariable Cox’s proportional hazard regression model to predict overall survival

From: External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

Variable HR (95% CI) P value
Sex (male vs. female) 0.81 (0.44–1.50) 0.510
Age (≤ 65 vs. > 65) 0.68 (0.42–1.10) 0.113
Diversion type (conduit vs. cutaneous ureterostomy) 1.52 (0.96–2.41) 0.072
Diversion type (neobladder vs. cutaneous ureterostomy) 0.59 (0.26–1.36) 0.218
Pathological T-stage (MIBC vs. NMIBC) 3.70 (2.19–6.26) < 0.001
Pathological N-stage (N + vs. N−) 2.08 (1.08–4.00) 0.028
Smoking history (yes vs. no) 1.23 (0.78–1.95) 0.381
Neoadjuvant chemotherapy (yes vs. no) 0.56 (0.20–1.57) 0.271
Pentafecta (yes vs. no) 0.33 (0.14–0.78) 0.011